(Q73339600)
Statements
Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo (English)
Della Porta P
Soeltl R
Krell HW
Collins K
O'Donoghue M
Schmitt M
1 September 1999